Clinical Trial Detail

NCT ID NCT02472392
Title Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Louisville
Indications

medulloblastoma

Therapies

Fludarabine

Cyclophosphamide

Melphalan

Busulfan

anti-thymocyte globulin

Age Groups: child adult

No variant requirements are available.